4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0001140361-08-000243
CIK 0000882104operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 1:32 PM ET
Size
14.1 KB
Accession
0001140361-08-000243
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Sale
Commom Stock
2008-01-02$17.06/sh−85$1,450→ 212 total - Sale
Common Stock
2008-01-02$17.14/sh−20$343→ 155 total - Sale
Common Stock
2008-01-02$17.41/sh−50$871→ 297 total - Sale
Common Stock
2008-01-02$17.12/sh−27$462→ 185 total - Sale
Common Stock
2008-01-02$17.26/sh−60$1,036→ 0 total - Sale
Common Stock
2008-01-02$17.19/sh−95$1,633→ 60 total
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Shares acquired under a Section 423 employee stock purchase plan on June 29, 2007.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 1:32 PM ET
- Size
- 14.1 KB